Search

Your search keyword '"Ugwuanyi, Ositadimma"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Ugwuanyi, Ositadimma" Remove constraint Author: "Ugwuanyi, Ositadimma"
12 results on '"Ugwuanyi, Ositadimma"'

Search Results

1. The BTLA–HVEM axis restricts CAR T cell efficacy in cancer

2. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

3. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

4. CAR T-Cell Immunotherapy in Minority Patients with Lymphoma

5. Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing

6. Overcoming CD19-Negative Relapses in Patients with B-Cell Lymphomas Treated with Tisagenlecleucel

7. Access and Outcomes of Minority Health Populations Receiving Commercial Anti-CD19 CART Therapy for Non-Hodgkin Lymphoma

8. A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19 in Adults with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

9. Precision Targeting of the Malignant Clone in Diffuse Large B Cell Lymphoma Using Chimeric Antigen Receptor T Cells Against the Clonotypic IGHV4-34 B Cell Receptor

11. Modulation of the Btla-HVEM Axis to Enhance CAR T Cell Immunotherapy Against Cancer

12. CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Catalog

Books, media, physical & digital resources